4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-049800
Chief Development Officer sold 678 shares at $114.51 ($77,639)
- Chief Development Officer acquired 678 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Guyer William Chief Development Officer | 2025-04-01 | Option exercise 10b5-1 | +678 | $21.65 | $14,679 | 6,165 | D |
| Guyer William Chief Development Officer | 2025-04-01 | Sale 10b5-1 | −678 | $114.51 | $77,639 | 5,487 | D |
| Derivatives | |||||||
| Guyer William Chief Development Officer | 2025-04-01 | Option exercise · Stock option (right to buy) 10b5-1 | −678 | 449,322 | D | ||
| Open-market sales · 678 sh · avg $114.51 · $77,639 | |||||||
Loading xslF345X05/ownership.xml…